tirzepatide vs semaglutide cardiovascular π In a large real-world study, was associated with a lower incidence of major outcomes semaglutide: π Composite CV outcome: 1.90% vs 2.18% (HR 0.86, p=0.01) β€οΈ New-onset heart Tirzepatide Vs semaglutide ,new data
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Nov 2 - Nov 7




























